Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,098,316 papers from all fields of science
Search
Sign In
Create Free Account
GTP 14564
Known as:
GTP-14564
, GTP14564
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Benzofurans
Pyrazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway
Q. Yao
,
R. Nishiuchi
,
T. Kitamura
,
J. Kersey
Leukemia
2005
Corpus ID: 29461131
17-allylamino-17-demethoxygeldanamycin (17-AAG), an inhibitor of the molecular chaperone heat shock protein 90, results in cell…
Expand
2004
2004
The Hsp90 Inhibitor 17-AAG and FLT3 Kinase Inhibitor GTP14564 Synergistically Inhibit MLL Fusion Gene Leukemias with FLT3 Mutations.
Q. Yao
,
R. Nishiuchi
,
T. Kitamura
,
J. Kersey
2004
Corpus ID: 88868537
17-AAG, an inhibitor of the molecular chaperone Hsp90, results in apoptosis and inhibition of proliferation of certain leukemia…
Expand
Highly Cited
2003
Highly Cited
2003
Selective Cytotoxic Mechanism of GTP-14564, a Novel Tyrosine Kinase Inhibitor in Leukemia Cells Expressing a Constitutively Active Fms-like Tyrosine Kinase 3 (FLT3)*
K. Murata
,
H. Kumagai
,
+9 authors
T. Kitamura
Journal of Biological Chemistry
2003
Corpus ID: 10044483
The receptor tyrosine kinase FLT3 is constitutively activated by an internal tandem duplication (ITD) mutation within the…
Expand
2003
2003
Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active FLT3 Running title: Essential roles of STAT5 in the mutant FLT3…
K. Murata
,
H. Kumagai
,
+7 authors
T. Kitamura
2003
Corpus ID: 86123206
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE